An open-label study of the safety, tolerability, and response rate of Xeloda in treatment-naïve patients with metastatic colorectal cancer.
Phase of Trial: Phase IV
Latest Information Update: 08 Oct 2015
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Roche
- 20 Jun 2008 New trial record.